WCN26-3077 PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF SEFAXERSEN IN CHINESE HEALTHY PARTICIPANTS: A RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, PHASE 1 STUDY